Cargando…
Inflammatory and Fibrotic Mediators in Renal Diseases
Autores principales: | Rayego-Mateos, Sandra, Goldschmeding, Roel, Ruiz-Ortega, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387726/ https://www.ncbi.nlm.nih.gov/pubmed/30881225 http://dx.doi.org/10.1155/2019/7025251 |
Ejemplares similares
-
Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
por: Rayego-Mateos, Sandra, et al.
Publicado: (2018) -
Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
por: Ruiz-Ortega, Marta, et al.
Publicado: (2020) -
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
por: Morgado-Pascual, Jose Luis, et al.
Publicado: (2019) -
CCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation
por: Rayego-Mateos, Sandra, et al.
Publicado: (2023) -
Mitochondrial Dysfunction in the Cardio-Renal Axis
por: Mendez-Barbero, Nerea, et al.
Publicado: (2023)